Featuring Michael B. Bracken, Ph.D., M.P.H., Susan Dwight Bliss Professor of Epidemiology and Public Health, Yale University; Michael Kamrin, Ph.D., Professor Emeritus, Michigan State University, Consultant in Toxicology and Risk Analysis; Henry Miller, M.D., Fellow, Hoover Institution, Stanford University; A. Alan Moghissi, Ph.D., President, Institute for Regulatory Science; Gilbert Ross, M.D., Medical Director, American Council on Science and Health; Kimberly M. Thompson, Sc.D., Associate Professor of Risk Analysis and Decision Science, Harvard Medical School, Creator and Director, Kids Risk Project, Harvard School of Public Health and Children’s Hospital, Boston; Peter Van Doren, Editor, Regulation; and Elizabeth Whelan, Sc.D., M.P.H., M.S., President and Founder, American Council on Science and Health.
In this landmark publication, ACSH’s team of nationally renowned scientists calls for a thorough, systemwide reassessment of the longstanding but scientifically unjustified practice of attempting to predict human cancer risk on the basis of high-dose animal tests. Using the most up-to-date research, America’s War on “Carcinogens” examines the drawbacks of a system that, while supposedly designed to prevent cancer, fails to distinguish actual from hypothetical human cancer risks. ACSH calls for our medical and regulatory agencies to abandon the current thoughtless assumption that a rodent is a little person. The book’s authors also urge Congress and the National Cancer Institute to take the lead in assisting the media, consumers, and regulatory agencies in distinguishing real from hypothetical cancer risks.